MBA Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
MBA Advisors's LLY Position: Q1 2026 in Review
MBA Advisors reduced its Eli Lilly (LLY) stake by 1.1% in Q1 2026, selling an estimated $6.08K and leaving 562 shares worth $517K. The position accounts for 0.2% of the portfolio, ranked #81.
MBA Advisors first reported a position in LLY in Q1 2021 and has held it in 21 quarters since. The position peaked at $664K in Q4 2023. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- MBA Advisors held 562 shares of Eli Lilly worth $517K as of Q1 2026.
- MBA Advisors sold 6 Eli Lilly shares in Q1 2026, an estimated $6.08K.
- Eli Lilly made up 0.2% of MBA Advisors's portfolio in Q1 2026, its #81 holding.
- MBA Advisors first reported a position in Eli Lilly in Q1 2021 and has held it in 21 quarters since.
- MBA Advisors's Eli Lilly position peaked at $664K in Q4 2023.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on MBA Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.